Literature DB >> 3264621

Amelogenesis imperfecta--clinical manifestations in 51 families in a northern Swedish county.

B Bäckman1.   

Abstract

The clinical manifestations of amelogenesis imperfecta (AI) were described in 165 individuals from 51 families. The inheritance pattern for AI in these families had previously been investigated, and it was hypothesized that AI probably is solely an autosomal dominant (AD) or X-linked trait. To test this hypothesis the connection between clinical manifestation and inheritance pattern was studied. Eight different variants of AI were seen. In 33/51 families all affected individuals could be assigned to the same clinical variant. In 8/51 families those affected were assigned to different clinical variants. In the two families where an X-linked recessive (XR) inheritance pattern was found probable, the clinical manifestation differed between women and men. Except for one variant only seen as an AD trait, and the manifestation in women in families with an X-linked recessive inheritance pattern, no connection was found between a specific inheritance pattern and a specific clinical manifestation. Accordingly it seems likely that AI is solely an AD or X-linked trait. The different clinical variants observed should be regarded as a varying expressivity of the gene and in the families with X-linked inheritance probably due to lyonization. In the remaining families the modifying mechanisms are not known.

Entities:  

Mesh:

Year:  1988        PMID: 3264621     DOI: 10.1111/j.1600-0722.1988.tb01590.x

Source DB:  PubMed          Journal:  Scand J Dent Res        ISSN: 0029-845X


  9 in total

1.  Amelogenesis imperfecta: genotype-phenotype studies in 71 families.

Authors:  J Timothy Wright; Melody Torain; Kimberly Long; Kim Seow; Peter Crawford; Michael J Aldred; P Suzanne Hart; Tom C Hart
Journal:  Cells Tissues Organs       Date:  2011-05-19       Impact factor: 2.481

2.  Target gene analyses of 39 amelogenesis imperfecta kindreds.

Authors:  Hui-Chen Chan; Ninna M R P Estrella; Rachel N Milkovich; Jung-Wook Kim; James P Simmer; Jan C-C Hu
Journal:  Eur J Oral Sci       Date:  2011-12       Impact factor: 2.612

Review 3.  The molecular etiologies and associated phenotypes of amelogenesis imperfecta.

Authors:  J Timothy Wright
Journal:  Am J Med Genet A       Date:  2006-12-01       Impact factor: 2.802

4.  Amelogenesis imperfecta: Report of a case and review of literature.

Authors:  Mayur Chaudhary; Shweta Dixit; Asha Singh; Sanket Kunte
Journal:  J Oral Maxillofac Pathol       Date:  2009-07

5.  A mutation in the mouse Amelx tri-tyrosyl domain results in impaired secretion of amelogenin and phenocopies human X-linked amelogenesis imperfecta.

Authors:  Martin J Barron; Steven J Brookes; Jennifer Kirkham; Roger C Shore; Charlotte Hunt; Aleksandr Mironov; Nicola J Kingswell; Joanne Maycock; C Adrian Shuttleworth; Michael J Dixon
Journal:  Hum Mol Genet       Date:  2010-01-12       Impact factor: 6.150

Review 6.  Multilevel complex interactions between genetic, epigenetic and environmental factors in the aetiology of anomalies of dental development.

Authors:  A H Brook
Journal:  Arch Oral Biol       Date:  2009-11-13       Impact factor: 2.633

7.  Enamel defects in extracted and exfoliated teeth from patients with Amelogenesis Imperfecta, measured using the extended enamel defects index and image analysis.

Authors:  R N Smith; C Elcock; A Abdellatif; B Bäckman; J M Russell; A H Brook
Journal:  Arch Oral Biol       Date:  2008-09-02       Impact factor: 2.633

8.  Amelogenesis imperfecta and localised aggressive periodontitis: A rare clinical entity.

Authors:  Gayatri Gundannavar; Radhika M Rosh; Shoba Chandrasekaran; Ahad M Hussain
Journal:  J Indian Soc Periodontol       Date:  2013-01

9.  Amelogenesis imperfecta in two families with defined AMELX deletions in ARHGAP6.

Authors:  Jan C-C Hu; Hui-Chen Chan; Stephen G Simmer; Figen Seymen; Amelia S Richardson; Yuanyuan Hu; Rachel N Milkovich; Ninna M R P Estrella; Mine Yildirim; Merve Bayram; Chiung-Fen Chen; James P Simmer
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.